Targeting inflammatory pathway reduces Alzheimer's disease in mice

December 15, 2014, Journal of Clinical Investigation

Alzheimer's disease (AD) is the most common form of dementia and is characterized by the formation of β-amyloid plaques throughout the brain. Proteins known as chemokines regulate inflammation and the immune response. In both patients with AD and mouse AD models, the chemokine CXCL10 is found in high concentrations in the brain and may contribute to AD.

A new study in the Journal of Clinical Investigation indicates that activation of the CXCL10 receptor, CXCR3, contributes to AD pathology. Using a murine model of AD, Michael Heneka and colleagues at the University of Bonn found that mice lacking CXCR3 had reduced β-amyloid plaque formation. Importantly, loss of CXCR3 signaling in AD mice attenuated .

The results of this study suggest that CXCR3 should be explored as a potential therapeutic target for AD.

Explore further: Inflammatory mediator enhances plaque formation in Alzheimer's disease

More information: CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer's disease model, J Clin Invest. DOI: 10.1172/JCI66771

Related Stories

Inflammatory mediator enhances plaque formation in Alzheimer's disease

September 7, 2011
Alzheimer's disease (AD) is a devastating neurodegenerative disorder that causes progressive cognitive impairment and memory loss. Now, a new study published by Cell Press in the September 8 issue of the journal Neuron identifies ...

Drugs targeting blood vessels may be candidates for treating Alzheimer's

March 7, 2013
(Medical Xpress)—University of British Columbia researchers have successfully normalized the production of blood vessels in the brain of mice with Alzheimer's disease (AD) by immunizing them with amyloid beta, a protein ...

Study examines association between small-vessel disease, Alzheimer pathology

May 12, 2014
Cerebral small-vessel disease (SVD) and Alzheimer disease (AD) pathology appear to be associated.

Bilingualism delays Alzheimer manifestation by more than four years

December 1, 2014
A new study at Ghent University has established that the symptoms of Alzheimer disease (AD) manifest themselves about four to five years later in bilinguals as opposed to monolinguals. In bilinguals, the disease onset was ...

'Alzheimer's in a Dish' model induces skin cells into neurons expressing amyloid-beta (w/ Video)

December 5, 2014
The search for a living laboratory model of human neurons in the grip of Alzheimer's disease (AD)—the so-called "Alzheimer's in a dish"—has a new candidate. In work presented at the ASCB/IFCB meeting in Philadelphia, ...

Study links enzyme to Alzheimer's disease

July 21, 2014
Unclogging the body's protein disposal system may improve memory in patients with Alzheimer's disease (AD), according to a study from scientists at Kyungpook National University in Korea published in The Journal of Experimental ...

Recommended for you

Meditation and music may alter blood markers of cellular aging and Alzheimer's disease

November 13, 2018
A research team led by Dr. Kim Innes, a professor in the West Virginia University School of Public Health, has found that a simple meditation or music listening program may alter certain biomarkers of cellular aging and Alzheimer's ...

Alzheimer's and cardiovascular disease share common genetics in some patients

November 9, 2018
Genetics may predispose some people to both Alzheimer's disease and high levels of blood lipids such as cholesterol, a common feature of cardiovascular disease, according to a new study by an international team of researchers ...

Artificial intelligence predicts Alzheimer's years before diagnosis

November 6, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer's disease, according to a study published in the journal Radiology.

Diabetes medications may reduce Alzheimer's disease severity

November 1, 2018
People with Alzheimer's disease who were treated with diabetes drugs showed considerably fewer markers of the disease—including abnormal microvasculature and disregulated gene expressions—in their brains compared to Alzheimer's ...

Massive study confirms that loneliness increases risk of dementia

October 29, 2018
A new Florida State University College of Medicine study involving data from 12,000 participants collected over 10 years confirms the heavy toll that loneliness can take on your health: It increases your risk of dementia ...

Bioactive compound from the Rhodiola plant improves memory

October 25, 2018
In an ageing society, more people are suffering from memory disorders. The progressive loss of memory severely impairs the quality of life of those affected. So far, no drugs are known to prevent age-related cognitive decline.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.